Aveo Pharmaceuticals Inc AVEO:NASDAQ

Set AlertOptionsStreaming Charts
Last Price$3.42NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/21/22

Today's Change-0.18(5.00%)
Bid (Size)$3.39 (2)
Ask (Size)$3.45 (26)
Day Low / High$3.39 - 3.61
Volume430.6 K
Sell
Buy
  • Latest Stories
  • Commentary and Analysis
AVEO Oncology Working With NiKang Therapeutics to Develop Combination Therapy for Kidney Cancer
11:22AM ET 1/05/2022 MT Newswires

AVEO Oncology (AVEO) and NiKang Therapeutics said Wednesday they are working together to develop a potential treatment for advanced clear cell renal cell...

Aveo Pharmaceuticals, Merck KgaA Enter Supply Deal for Head, Neck Cancer Trial
10:35AM ET 1/04/2022 MT Newswires

Aveo Pharmaceuticals (AVEO) said Tuesday it entered a clinical trial collaboration and supply agreement with Merck KgaA to evaluate ficlatuzumab in...

AVEO Pharmaceuticals Names Jeb Ledell as Operations Chief
7:39AM ET 12/01/2021 MT Newswires

AVEO Pharmaceuticals (AVEO) said Wednesday it has appointed Jeb Ledell as chief operating officer. Ledell previously served as operations chief at...

-- Earnings Flash (AVEO) AVEO ONCOLOGY Posts Q3 Revenue $15.2M, vs. Street Est of $13.8M
4:10PM ET 11/08/2021 MT Newswires

...

Aveo Pharmaceuticals' Head, Neck Cancer Drug Gets FDA Fast-Track Designation
9:23AM ET 9/20/2021 MT Newswires

Aveo Pharmaceuticals (AVEO) said Monday the US Food and Drug Administration granted ficlatuzumab, its investigational drug being developed for the...

-- Earnings Flash (AVEO) AVEO ONCOLOGY Reports Q2 Revenue $7.6M, vs. Street Est of $6.96M
4:17PM ET 8/05/2021 MT Newswires

...

--HC Wainwright Adjusts Price Target on AVEO Pharmaceuticals to $19 From $27, Keeps Buy Rating
7:23AM ET 7/12/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (AVEO) AVEO ONCOLOGY Reports Q1 Revenue $1.9M, vs. Street Est of $1.01M
4:07PM ET 5/10/2021 MT Newswires

...

AVEO's Fotivda Gets Added to National Comprehensive Cancer Network Clinical Practice Guidelines
9:51AM ET 3/29/2021 MT Newswires

AVEO Oncology (AVEO) said Monday that the National Comprehensive Cancer Network included Fotivda as a recommended regimen for subsequent therapy for...

AVEO Oncology Raises $55.2 Million From Stock Offering
4:17PM ET 3/26/2021 MT Newswires

AVEO Oncology (AVEO) said Friday that it closed the public offering of 6.9 million common shares, including 900,000 shares purchased by the underwriters...

1
2